Published in Antimicrob Agents Chemother on July 01, 1983
Occurrence of a beta-lactam-inducible penicillin-binding protein in methicillin-resistant staphylococci. Antimicrob Agents Chemother (1985) 6.19
In vitro activities of enoxacin, ticarcillin plus clavulanic acid, aztreonam, piperacillin, and imipenem and comparison with commonly used antimicrobial agents. Antimicrob Agents Chemother (1985) 1.13
Imipenem therapy of experimental Staphylococcus epidermidis endocarditis. Antimicrob Agents Chemother (1986) 0.92
Interactions between glycopeptides and beta-lactams against isogenic pairs of teicoplanin-susceptible and -resistant strains of Staphylococcus haemolyticus. Antimicrob Agents Chemother (2006) 0.85
Inducibly cefoxitin-resistant Macrococcus-like organism falsely identified as methicillin-resistant Staphylococcus aureus on CHROMagar with oxacillin. J Clin Microbiol (2010) 0.77
Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol (1966) 159.00
A new type of penicillin resistance of Staphylococcus aureus. Lancet (1977) 9.15
Purification and properties of inducible penicillin beta-lactamase isolated from Pseudomonas maltophilia. Antimicrob Agents Chemother (1982) 7.11
Replication and expression of plasmids from Staphylococcus aureus in Bacillus subtilis. Proc Natl Acad Sci U S A (1977) 5.55
Aminoglycoside antibiotic-inactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria. Proc Natl Acad Sci U S A (1973) 5.20
Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability. Antimicrob Agents Chemother (1982) 4.45
In vitro activity of N-formimidoyl thienamycin (MK0787). Antimicrob Agents Chemother (1980) 3.90
Plasmid-mediated penicillin beta-lactamases in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1976) 3.40
Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism. Antimicrob Agents Chemother (1982) 3.30
Transduction of Methicillin Resistance in Staphylococcus aureus Dependent on an Unusual Specificity of the Recipient Strain. J Bacteriol (1970) 3.21
Escherichia coli resistance to beta-lactam antibiotics through a decrease in the affinity of a target for lethality. Nature (1978) 2.92
Staphylococcus saprophyticus: a frequent cause of acute urinary tract infection among female outpatients. J Infect Dis (1978) 2.74
Effect of N-formimidoyl thienamycin (MK0787) on beta-lactamases and activity against beta-lactamase-producing strains. Antimicrob Agents Chemother (1980) 2.53
Alteration of 23 S ribosomal RNA and erythromycin-induced resistance to lincomycin and spiramycin in Staphylococcus aureus. J Mol Biol (1973) 2.51
In vitro activity of N-formimidoyl thienamycin (MK0787) against resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens, and Enterococcus spp. Antimicrob Agents Chemother (1981) 2.48
Further observations on the zone phenomenon in the bactericidal action of penicillin. J Bacteriol (1951) 2.42
Coagulase-negative staphylococci and micrococci in urinary tract infections. J Clin Pathol (1975) 2.31
Common R-plasmids in Staphylococcus aureus and Staphylococcus epidermidis during a nosocomial Staphylococcus aureus outbreak. Antimicrob Agents Chemother (1982) 2.27
Staphylococci as urinary pathogens. J Clin Pathol (1977) 2.22
Endocarditis due to Micrococci and Staphylococcus epidermidis. Arch Intern Med (1973) 2.12
Closely related plasmids from Staphylococcus aureus and soil bacilli. Plasmid (1982) 2.02
Origin and function of penicillinase: a problem in biochemical evolution. Br Med J (1967) 1.72
How do antibiotic-producing microorganisms avoid suicide? Ann N Y Acad Sci (1974) 1.60
Antibiotic resistance in pathogenic and producing bacteria, with special reference to beta-lactam antibiotics. Microbiol Rev (1981) 1.58
Aminoglycoside-modifying enzyme of an antibiotic-producing bacterium acts as a determinant of antibiotic resistance in Escherichia coli. Proc Natl Acad Sci U S A (1977) 1.57
Staphylococcal plasmids that replicate and express erythromycin resistance in both Streptococcus pneumoniae and Escherichia coli. Proc Natl Acad Sci U S A (1982) 1.54
Transduction of methicillin resistance in Staphylococcus aureus: recipient effectiveness and beta-lactamase production. Antimicrob Agents Chemother (1980) 1.51
Naturally occurring constitutive -lactamase of novel serotype in Staphylococcus aureus. J Gen Microbiol (1973) 1.21
In vitro comparison of N-formimidoyl thienamycin, piperacillin, cefotaxime, and cefoperazone. Antimicrob Agents Chemother (1981) 1.07
Antibiotic tolerance in producer organisms. Adv Appl Microbiol (1979) 0.99
McrA and McrB restriction phenotypes of some E. coli strains and implications for gene cloning. Nucleic Acids Res (1988) 5.76
An immunological relationship between the group. A streptococcus and mammalian muscle. J Exp Med (1966) 4.89
Type-specific polysaccharide antigens of group B streptococci. J Hyg (Lond) (1966) 4.55
Structure-guided analysis reveals nine sequence motifs conserved among DNA amino-methyltransferases, and suggests a catalytic mechanism for these enzymes. J Mol Biol (1995) 4.10
The isolation and characterization of the Escherichia coli DNA adenine methylase (dam) gene. Nucleic Acids Res (1983) 2.94
Type-specific polysaccharide antigens of group B streptococci. II. The chemical basis for serological specificity of the type II HCl antigen. J Exp Med (1967) 2.92
Cloning of a restriction-modification system from Proteus vulgaris and its use in analyzing a methylase-sensitive phenotype in Escherichia coli. J Bacteriol (1985) 2.92
A family of regulatory genes associated with type II restriction-modification systems. J Bacteriol (1991) 2.60
Regulation of transcription factor rho and the alpha subunit of RNA polymerase in Escherichia coli B/r. Proc Natl Acad Sci U S A (1976) 2.29
Sequence, internal homology and high-level expression of the gene for a DNA-(cytosine N4)-methyltransferase, M.Pvu II. Nucleic Acids Res (1989) 2.15
Structure of pvu II DNA-(cytosine N4) methyltransferase, an example of domain permutation and protein fold assignment. Nucleic Acids Res (1997) 1.84
Proteins Specified by bovine herpesvirus 1 (infectious bovine rhinotracheitis virus). J Virol (1981) 1.80
Regulation of the gltBDF operon of Escherichia coli: how is a leucine-insensitive operon regulated by the leucine-responsive regulatory protein? J Bacteriol (1993) 1.78
The effects of the relA gene on the synthesis of aminoacyl-tRNA synthetases and other transcription and translation proteins in Escherichia coli A. Mol Gen Genet (1976) 1.72
Mapping regulatory networks in microbial cells. Trends Microbiol (1999) 1.62
Role and mechanism of action of C. PvuII, a regulatory protein conserved among restriction-modification systems. J Bacteriol (2000) 1.60
Computer programs for nucleic acid sequence manipulation. Nucleic Acids Res (1982) 1.60
Finding a basis for flipping bases. Structure (1996) 1.48
Sequence and characterization of pvuIIR, the PvuII endonuclease gene, and of pvuIIC, its regulatory gene. J Bacteriol (1992) 1.41
A mutant of Escherichia coli with an altered elongation factor Tu. Proc Natl Acad Sci U S A (1976) 1.36
Assignment of enzymatic function to specific protein regions of cobalamin-dependent methionine synthase from Escherichia coli. Biochemistry (1993) 1.26
Comparative in vitro activities of N-formimidoyl thienamycin and moxalactam against nonfermentative aerobic gram-negative rods. Antimicrob Agents Chemother (1982) 1.22
Host-mediated modification of PvuII restriction in Mycobacterium tuberculosis. J Bacteriol (1996) 1.20
Analysis of genes encoding two unique type IIa immunoglobulin G-binding proteins expressed by a single group A streptococcal isolate. Infect Immun (1994) 1.20
The leucine-responsive regulatory protein of Escherichia coli negatively regulates transcription of ompC and micF and positively regulates translation of ompF. J Bacteriol (1995) 1.15
Protection of mice from group A streptococcal skin infection by interleukin-12. J Infect Dis (1995) 1.12
Empirical use of imipenem as the sole antibiotic in the treatment of serious infections. J Antimicrob Chemother (1985) 1.12
A nucleoprotein activation complex between the leucine-responsive regulatory protein and DNA upstream of the gltBDF operon in Escherichia coli. J Mol Biol (1997) 1.11
Nomenclature for bacterial genes coding for class-II restriction endonucleases and modification methyltransferases. Gene (1988) 1.10
In vitro evaluation of the new oral cephalosporin cefatrizine: comparison with other cephalosporins. Antimicrob Agents Chemother (1976) 1.04
Identification of two type IIa IgG-binding proteins expressed by a single group A streptococcus. J Immunol (1992) 1.02
Bovine rotavirus-cell interactions: effect of virus infection on cellular integrity and macromolecular synthesis. Virology (1981) 1.02
Gene expression in Escherichia coli B/r during partial rifampicin-mediated restrictions of transcription initiation. Mol Gen Genet (1978) 1.01
Role of emm and mrp genes in the virulence of group A streptococcal isolate 64/14 in a mouse model of skin infection. J Infect Dis (1998) 1.01
Activation from a distance: roles of Lrp and integration host factor in transcriptional activation of gltBDF. J Bacteriol (2001) 0.99
Identification of key gene products required for acquisition of plasmin-like enzymatic activity by group A streptococci. J Infect Dis (1997) 0.95
The M.AluI DNA-(cytosine C5)-methyltransferase has an unusually large, partially dispensable, variable region. Nucleic Acids Res (1993) 0.94
Use of an in vivo titration method to study a global regulator: effect of varying Lrp levels on expression of gltBDF in Escherichia coli. J Bacteriol (1996) 0.94
Effect of dietary protein deprivation on insulin-like growth factor (IGF)-I and -II, IGF binding protein-2, and serum albumin gene expression in rat. Endocrinology (1990) 0.94
Gene pvuIIW: a possible modulator of PvuII endonuclease subunit association. Gene (1995) 0.93
Effect of fasting on insulin-like growth factor-I (IGF-I) and growth hormone receptor mRNA levels and IGF-I gene transcription in rat liver. Mol Endocrinol (1990) 0.90
Analysis of macromolecular biosynthesis to define the quinolone-induced postantibiotic effect in Escherichia coli. Antimicrob Agents Chemother (1992) 0.90
Detection of protein A-like substances on haemolytic streptococci prior to use in mixed reverse passive antiglobulin haemagglutination (MRPAH). J Immunol Methods (1979) 0.90
Treatment of skin and soft tissue infections with imipenem/cilastatin. Am J Med (1985) 0.89
Osteomyelitis caused by viridans streptococci. Arch Intern Med (1982) 0.89
The PvuII DNA (cytosine-N4)-methyltransferase comprises two trypsin-defined domains, each of which binds a molecule of S-adenosyl-L-methionine. Biochemistry (1997) 0.89
Treatment of serious infections with moxalactam. Am J Med (1983) 0.88
Oxolinic acid for the treatment of chronic gastrointestinal Shigella carriers. Am J Trop Med Hyg (1978) 0.88
Recognition of native DNA methylation by the PvuII restriction endonuclease. Nucleic Acids Res (2000) 0.87
Use of an inducible regulatory protein to identify members of a regulon: application to the regulon controlled by the leucine-responsive regulatory protein (Lrp) in Escherichia coli. J Bacteriol (1997) 0.86
Autoimmune mechanisms in the pathogenesis of rheumatic fever. Rev Infect Dis (1985) 0.86
A randomized study comparing clinical efficacy and safety of thienamycin formamidine (MK0787)/renal dipeptidase inhibitor (MK0791) and cefazolin. J Antimicrob Chemother (1983) 0.86
Infection with Cryptococcus neoformans var. gattii leading to a pulmonary cryptococcoma and meningitis. J Infect (1984) 0.85
Characterization of pPvu1, the autonomous plasmid from Proteus vulgaris that carries the genes of the PvuII restriction-modification system. Gene (1995) 0.85
Pharmacokinetics of imipenem-cilastatin in patients with renal insufficiency undergoing continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother (1988) 0.85
Insulin negatively regulates albumin mRNA at the transcriptional and post-transcriptional level in rat hepatoma cells. J Biol Chem (1987) 0.84
Inactivation of single genes within the virulence regulon of an M2 group A streptococcal isolate result in differences in virulence for chicken embryos and for mice. Microb Pathog (1997) 0.84
Substrate recognition by the Pvu II endonuclease: binding and cleavage of CAG5mCTG sites. Nucleic Acids Res (1999) 0.83
Detection of streptococcal class I M protein in psoriasis by confocal immunofluorescent microscopy. Acta Derm Venereol (1997) 0.83
Pathogenesis and treatment of endocarditis. Am J Med (1985) 0.83
Spontaneous carditis in the NZB mouse and its hybrids. Arthritis Rheum (1974) 0.83
Gene expression in Escherichia coli after amino acid, purine, or pyrimidine exhaustion. J Bacteriol (1980) 0.83
Expression, purification, mass spectrometry, crystallization and multiwavelength anomalous diffraction of selenomethionyl PvuII DNA methyltransferase (cytosine-N4-specific). Eur J Biochem (1997) 0.82
A Taq attack displaces bases. Nat Struct Biol (2001) 0.82
Cell-mediated immunity in systemic lupus erythematosus: alterations with advancing age. J Lab Clin Med (1975) 0.82
Regulation of ribonucleic acid polymerase synthesis during restriction of an Escherichia coli mutant temperature sensitive for transcription factor sigma. J Bacteriol (1980) 0.81
Laboratory rats from commercial breeders as carriers of pathogenic pneumococci. Lab Anim Care (1969) 0.81
Ceftizoxime elimination kinetics in continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther (1983) 0.79
Autoimmune cell-mediated responses: spontaneous responses to syngeneic cells in NZB/NZW F1 mice. J Immunol (1979) 0.79
T lymphocyte abnormalities in disseminated histoplasmosis. Am J Med (1983) 0.78
Characterization of a gene coding for a type IIo bacterial IgG-binding protein. Mol Immunol (1995) 0.78
Specific decrease in liver insulin-like growth factor-I and brain insulin-like growth factor-II gene expression in energy-restricted rats. J Nutr (1991) 0.78
Regulation of albumin mRNA in H4 rat hepatoma cells by the availability of essential amino acids. Biochim Biophys Acta (1988) 0.77
Spontaneous and induced cell-mediated reactivity to syngeneic cells. Nature (1977) 0.76
Rheumatic fever. Sci Am (1965) 0.76
Cefotetan-induced disulfiram-type reactions and hypoprothrombinemia. Antimicrob Agents Chemother (1987) 0.75
Unusual manifestations of gastrointestinal Kaposi's sarcoma in acquired immunodeficiency syndrome. Arch Dermatol (1988) 0.75
Detection of antibiotic-induced platelet dysfunction in whole blood using flow cytometry. J Antimicrob Chemother (1992) 0.75
Infectious antecedent of immunoblastic lymphoma. Progressive immunosuppression in a patient with lymphogranuloma venereum. Am J Med (1985) 0.75
Response of peripheral blood lymphocytes from the (NZB/NZW)F1 mouse to phytohemagglutinin. Clin Immunol Immunopathol (1976) 0.75
Occult Streptococcus pyogenes in cellulitis: demonstration by immunofluorescence. Br J Dermatol (1995) 0.75
Tetanus. Am Fam Physician (1976) 0.75
Inhibition of platelet aggregation by moxalactam and free N-methylthiotetrazole. Clin Ther (1989) 0.75
Rupture of a pulmonary artery mycotic aneurysm associated with candidal endocarditis. Am J Med (1988) 0.75
A genetic and functional analysis of the unusually large variable region in the M.AluI DNA-(cytosine C5)-methyltransferase. Mol Gen Genet (1997) 0.75
Do chickens immunized with bacterial immunoglobulin G-binding proteins produce rheumatoid factor-like antibodies? Scand J Immunol (1998) 0.75
Amino acid limitation negatively regulates insulin-like growth factor-II mRNA levels and E-domain peptide secretion at a post-transcriptional step in BRL-3A rat liver cells. J Biol Chem (1988) 0.75
Letter: Ageing, immune response, and mortality. Lancet (1974) 0.75
Clinical experience with cefoxitin sodium. J Antimicrob Chemother (1978) 0.75
Treatment of significant bacterial infections in adults with cefoxitin. Rev Infect Dis (1989) 0.75
A Behçet-like disease presenting as ulcerative stomatitis and scarring pustular lesions of the face. Cutis (1997) 0.75